Table 2.
Incidence of endometrial SIX1 expression in patients with different histopathological diagnoses
| Category | Diagnosis | # Patients | # SIX1- Positive |
# SIX1- Negative |
%SIX1- Positive |
|---|---|---|---|---|---|
| Normal | Normal | 28 | 0 | 28 | 0% |
| Nonneoplastic | Normal cancer adjacent tissue | 13 | 0 | 13 | 0% |
| Hyperplasia | 21 | 0 | 21 | 0% | |
| Inflammation | 5 | 0 | 5 | 0% | |
| Preneoplastic | Atypical hyperplasia | 3 | 1 | 2 | 33% |
| Neoplastic | Endometrioid adenocarcinoma | 171 | 43 | 128 | 25% |
| Unspecified adenocarcinoma | 87 | 28 | 59 | 32% | |
| Serous carcinoma | 11 | 4 | 7 | 36% | |
| Clear cell carcinoma | 4 | 0 | 4 | 0% | |
| Mucinous carcinoma | 1 | 1 | 0 | 100% | |
| Adenocarcinoma metastasis | 5 | 0 | 5 | 0% | |
| Adenosquamous carcinoma | 7 | 1 | 6 | 14% | |
| Squamous carcinoma | 8 | 3 | 5 | 38% | |
| Undifferentiated carcinoma | 2 | 0 | 2 | 0% | |
| Stromal sarcoma | 1 | 0 | 1 | 0% | |
| Chorionic carcinoma | 2 | 0 | 2 | 0% |